BAJAJ BROKING

Notification
No new Notification messages
Suraksha Diagnostic IPO is Open!
Apply for the Suraksha Diagnostic IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Nephro Care India Ltd

Healthcare

Offer Period :

28th to 2nd Jul 2024

Nephro Care India Ltd, established in 2014, is a healthcare provider that specializes in the treatment of kidney-related diseases. It is planning a ₹41.26 crore IPO. Read more... The company is a one-stop clinic with headquarters in Kolkata. It offers treatment for patients with renal insufficiency as well as a variety of clinical and lifestyle options. Read less

Nephro Care India Ltd IPO Details

IPO Date 28th to 2nd Jul 2024 Minimum Investment ₹144000 / 1 Lots
Listing Date 2024-07-05 Maximum Investment ₹144000 / 1 Lots
Face Value ₹10 per share Total Issue Size ₹41.26 Crores
Price ₹90 to ₹90 per share Fresh Issue ₹41.26 Crores
Lot Size 1 Lots (1600 Shares) Offer For Sale ₹ 0
Listing At NSE-SME Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date 28th to 2nd Jul 2024
Listing Date 2024-07-05
Face Value ₹10 per share
Price ₹90 to ₹90 per share
Lot Size 1 Lots (1600 Shares)
Listing At NSE-SME
Employee Discount ₹0 per share
Minimum Investment ₹144000 / 1 Lots
Maximum Investment ₹144000 / 1 Lots
Total Issue Size ₹41.26 Crores
Fresh Issue ₹41.26 Crores
Offer For Sale
Retail Discount ₹ 0

Timeline

Important dates for allocation and IPO listing.

28th Jun

IPO Starts

2nd Jul

IPO Ends

3rd Jul

Allotment Date

4th Jul

Initiation of Refund

4th Jul

Credit of Shares to Demat Account

5th Jul

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 84.02 60.66
Public Group 15.98 39.34

Nephro Care India Ltd IPO Reservation

QIB Shares Offered 2064000(45.03%)
NII (HNI) Shares Offered 619200(13.51%)
Retail Shares Offered 1444800(31.52%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 4584000
Total Shares With Anchor Investor 4584000

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Nephro Care India Ltd IPO Registrar

Bigshare Services Pvt Ltd
Phone Number +91-22-62638200
Email Id ipo@bigshareonline.com
Our Website www.bigshareonline.com

Nephro Care India Ltd IPO Lead Manager

1. Corporate Capitalventures Pvt Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Nephro Care India Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
QIB 8,25,600 20,23,87,200 5,72,611.0
Non Institutional Investors 8,49,600 1,10,68,56,000 5,72,611.0
Retail Individual Investors (RIIs) 14,44,800 91,61,77,600 5,72,611.0
emp 2,25,600 46,11,200 5,72,611.0
Total 33,45,600 2,23,00,32,000 5,72,611.0

Strength of Nephro Care India Ltd

1. We bridge the gap between day care and tertiary care services by addressing unmet needs through a blend of modern medical science and time tested yogic wisdom for overall wellbeing of the patients.

2. Our technology backbone is robust and supports consistent improvements in the quality and efficiency of our service delivery.

3. Track record of operating and financial performance and growth.

4. Professional management and experienced leadership.

5. Investment in infrastructure, processes and clinical services delivery framework, affordability resulting in a strong value proposition for stakeholders.

Risks Involved

1. Its Promoter, Dr. Pratim Sengupta, plays a key role in the company functioning and its heavily relies on his knowledge and experience in operating its business and therefore, it is critical for the company's business that its Promoter remain associated with the company.

2. Its expansion into new business vertical, i.e. setting up a hospital, may expose the company to new challenges and more risks.

3. The company's revenues are significantly dependent on its flagship Salt Lake clinic. Further, all its clinics are located in the Kolkata. Any impact on the revenues of its flagship Salt Lake clinic or any change in the economic or political circumstances of West Bengal or particularly in or around Kolkata, could materially affect its business, financial condition and results of operations.

4. The company is highly dependent on its healthcare professionals including doctors and nurses, and any future inability to attract/ retain such professionals will adversely affect its business, financial condition and results of operations.

5. Its industry is highly regulated and requires it to obtain, renew and maintain statutory and regulatory permits, accreditations, licenses and comply with applicable safety, health, environmental, labour and other governmental regulations. Any regulatory changes or violations of such rules and regulations may adversely affect its business, financial condition and results of operations.

6. The company incur high expenses in relation to manpower cost, infrastructure and medical maintenance and repair costs, ancillary and various pharmaceuticals items. If the company is unable to obtain favourable pricing from suppliers or negotiate compensation of its healthcare professionals effectively, it could affect its profitability. Any inability to pass on such costs to its patients, may have an adverse impact on its business, financial condition and results of operations.

7. There can be no assurance that the objects of the Issue will be achieved within the time frame anticipated or at all, or that the deployment of the Net Proceeds in the manner intended by it will result in any increase in the value of your investment. Further, the plan for deployment of the Net Proceeds has not been appraised by any bank or financial institution.

8. Its ability to provide affordable healthcare depends on the maintenance of a high volume of patients and effective capital management. Any increase in such costs could adversely affect its business, financial condition and results of operations.

9. The Company is yet to place orders for the equipments and machines required for its proposed multi-speciality hospital. Any delay in placing orders or procurement of such equipment, may further delay the schedule of implementation and increase the cost of commissioning the manufacturing units.

10. The company may experience delays in commencement of operations of its proposed hospital or the company may be unsuccessful in implementing its growth plans of expansion in a timely manner or at all, which may have an adverse effect on its business, financial condition and results of operations.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
 
Total Assets
Total Liabilities
Total Expenses
Total Revenue 
Profit After Tax
EBITDA
Adjusted EBITDA

Nephro Care India Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2024-07-05 92991 NEPHROCARE
INE0SUN01013
₹0 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹90 ₹90
Open ₹0 ₹171
Low ₹0 ₹171
High ₹0 ₹179.55
Low ₹0 ₹171

Frequently Asked Questions

What is Nephro Care India Ltd IPO?

Answer Field

Nephro Care India Ltd IPO is a SME IPO of 45,84,000 equity shares of a face value of ₹10 aggregating up to ₹41.26 Crores. The issue is priced at ₹90 to ₹90 per share. The minimum order quantity is 1600 Shares. The IPO opens on June 28, 2024, and closes on July 02, 2024. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Nephro Care India Ltd IPO will open?

Answer Field

The Nephro Care India Ltd IPO opens on June 28, 2024 and closes on July 02, 2024.

What is the lot size of Nephro Care India Ltd?

Answer Field

Nephro Care India Ltd lot size is 1600 shares, and the minimum amount required is ₹1,44,000.

How to apply for Nephro Care India Ltd IPO?

Answer Field

You can apply in Nephro Care India Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Nephro Care India Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Nephro Care India Ltd IPO will be done on July 03, 2024, and the allotted shares will be credited to your demat account by July 04, 2024.

When is Nephro Care India Ltd IPO listing date?

Answer Field

The Nephro Care India Ltd listing date is July 05, 2024.

Who is the registrar of Nephro Care India Ltd IPO?

Answer Field

The registrar of Nephro Care India Ltd IPO is Bigshare Services Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Corporate Capitalventures Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Nephro Care India Ltd IPO?

Answer Field

The fresh issue size is ₹41.26 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Nephro Care India Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1600 shares and ₹1,44,000 amount.

How can I approve the UPI mandate request for Nephro Care India Ltd IPO?

Answer Field

To apply for Nephro Care India Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Nephro Care India Ltd?

Answer Field

The price of each Nephro Care India Ltd share will be ranging in between ₹90 to ₹90 per share.

What is the cut-off time for the UPI mandate for Nephro Care India Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, July 02, 2024.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SURAKSHA DIAGNOSTIC LIMITEDMainboard IPO

  • Bidding Dates

    29th Nov 2024 - 12th Dec 2024

  • Price Range

    ₹420.0 - 441.0

  • IPO Size

    ₹8,46,25,00,000

  • Apply Now
  • GANESH INFRAWORLD LIMITEDSME IPO

  • Bidding Dates

    29th Nov 2024 - 12th Dec 2024

  • Price Range

    ₹78.0 - 83.0

  • IPO Size

    ₹98,57,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SWIGGY LIMITEDMainboard IPO

  • Bidding Dates

    6th Nov 2024 - 11th Nov 2024

  • Price Range

    ₹371.0 - 390.0

  • IPO Size

    ₹1,13,27,43,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • ONYX BIOTEC LIMITEDSME IPO

  • Issue Price

    61.00

  • Listing Day Close

    56.75

  • Listing Day (Gain/Loss)

    -6.56

  • SWIGGY LIMITEDMainboard IPO

  • Issue Price

    390.00

  • Listing Day Close

    455.95

  • Listing Day (Gain/Loss)

    16.92

  • DANISH POWER LIMITEDSME IPO

  • Issue Price

    380.00

  • Listing Day Close

    598.50

  • Listing Day (Gain/Loss)

    57.63

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text